ADCETRIS® Patient Management – Indications and Dosing
The purpose of this meeting will be to educate healthcare professionals on the role of ADCETRIS (brentuximab vedotin) for injection in the treatment of relapsed Hodgkin lymphoma.
Healthcare Professionals including Hematologist Oncologists, Medical Oncologists, Pathologists, Pharmacists, PAs, NPs, and RNs are encouraged to participate in this valuable dialogue.
Stephany Rodriguez, RN, MS, NP
University of California